MarketPulse

small cell lung cancer

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Molecular Partners to Showcase Experimental Cancer Therapy MP0712 at Major 2026 Conferences

Molecular Partners will present its DLL3-targeting Radio-DARPin candidate MP0712 at three major scientific conferences in May 2026, highlighting early clinical trial data.
MOLNclinical developmentsmall cell lung cancer
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Boehringer Ingelheim, Zai Lab Partner on DLL3 Combo Therapy for Lung Cancer

Boehringer Ingelheim and Zai Lab collaborate on Phase Ib/II study combining T-cell engager obrixtamig with ADC zocilurtatug for small cell lung cancer treatment.
ZLABADC (antibody drug conjugate)immuno-oncology
BenzingaBenzinga··Vandana Singh

Tempus AI Surges on AACR Data Windfall Despite Jefferies Skepticism

Tempus AI shares jumped 7.3% to $49.34 after 31 cancer research abstracts were accepted for AACR conference, though analyst coverage turns cautious.
TEMcolorectal cancerprecision medicine
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Allarity Therapeutics Secures $20M Funding to Accelerate Stenoparib FDA Path

Allarity Therapeutics secures $20M non-dilutive debt financing to complete stenoparib Phase 2 trial and advance toward FDA approval, extending runway to mid-2028.
ALLRFDA approvaldebt financing